<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02449070</url>
  </required_header>
  <id_info>
    <org_study_id>D-1407-011-030</org_study_id>
    <nct_id>NCT02449070</nct_id>
  </id_info>
  <brief_title>Effects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction</brief_title>
  <official_title>Effects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction : A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pusan National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>JW Pharmaceutical</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Pusan National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether nicorandil reduce cardiac infarct size in
      patient with ST-segment elevation acute myocardial infarction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study objective :

      To investiage whether nicorandil treatment reduce infarct size measured by cardiac MRI at 6
      months after primary PCI

      Allocation :

        1. Nicorandil arm :

           Recieve nicorandil 4 mg i.v. before undergoing PCI, additionall 2mg i.c. just before 1st
           ballooning, additionall 2mg i.c. just before stenting, After successful PCI, 10 mg/day
           (or 5 mg/day) p.o. for 6 months.

        2. Control arm :

      Recieve standard treatment including PCI, but avoid nicoranil and adenosine.

      Follow-up and Measurement :

      Cardiac MRI scans are scheduled at 5 days and 6 months after primary PCI. Clinically followed
      upto 6 months after parimary PCI.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infarct size as measured by cardiac MRI</measure>
    <time_frame>Six months after primary PCI</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>LVEF(%) as measured by cardiac MRI</measure>
    <time_frame>Five days and 6 months after primary PCI</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MVO as measured by cardiac MRI</measure>
    <time_frame>Five days after primary PCI</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ST-segment resolution</measure>
    <time_frame>One hour after primary PCI</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE (Death, Spontaneous MI, Stroke)</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">86</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Nicorandil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receive nicorandil before primary PCI and thereafter for 6 months along with the standard therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Receive primary PCI and the standard therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicorandil</intervention_name>
    <description>4 mg iv after randomization, 2 mg ic just before ballooning, 2 mg ic just before stenting</description>
    <arm_group_label>Nicorandil</arm_group_label>
    <other_name>Nicrodandil</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  STEMI patients presenting within 12 hours after symptom onset

          -  Undergoing primary PCI

        Exclusion Criteria:

          -  Previous myocardial infarction

          -  Atrial fibrillation

          -  RV infarction

          -  Cardiogenic shock

          -  Serum creatinine &gt;2.0 mg/dL

          -  Narrow angle glaucoma

          -  Taking PDE-5 inhibitors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jun-Hyok Oh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pusan National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jun-Hyok Oh, MD</last_name>
    <phone>82-51-240-7794</phone>
    <email>jhoh724@hanmail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pusan National University Hospital</name>
      <address>
        <city>Pusan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun-Hyok Oh, MD</last_name>
      <email>jhoh724@hanmail.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2015</study_first_submitted>
  <study_first_submitted_qc>May 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2015</study_first_posted>
  <last_update_submitted>September 18, 2017</last_update_submitted>
  <last_update_submitted_qc>September 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pusan National University Hospital</investigator_affiliation>
    <investigator_full_name>Jun-Hyok OH</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Nicorandil</keyword>
  <keyword>Cardiac MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicorandil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

